MRI only conversion to multiple sclerosis following a clinically isolated syndrome

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2010-06-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp.2010.208660PMID 20519235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early MRI in optic neuritis: The risk for disability

  2010cited by this paper
• MRI criteria for MS in patients with clinically isolated syndromes

  2010cited by this paper
• A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.

  2009cited by this paper
• Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial.

  2009cited by this paper
• Early MRI in optic neuritis

  2009cited by this paper
• Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease

  2008cited by this paper
• Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up.

  2008cited by this paper
• Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis.

  2008cited by this paper
• Primary-progressive multiple sclerosis.

  2007cited by this paper
• MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study.

  2007influential reference
• Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

  2006cited by this paper
• Baseline MRI predicts future attacks and disability in clinically isolated syndromes

  2006cited by this paper
• Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

  2006cited by this paper
• Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

  2005cited by this paper
• Long-term brain magnetic resonance imaging changes after optic neuritis in patients without clinically definite multiple sclerosis.

  2004cited by this paper
• Pubertal Growth Assessment

  2003cited by this paper
• A longitudinal study of abnormalities on MRI and disability from multiple sclerosis.

  2002cited by this paper
• Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis

  2002cited by this paper
• A LONGITUDINAL STUDY OF ABNORMALITIES ON MRI AND DISABILITY FROM MULTIPLE SCLEROSIS

  2002cited by this paper
• Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study.

  2001cited by this paper
• Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

  2001cited by this paper
• Diagnostic criteria for multiple sclerosis.

  2001cited by this paper
• Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

  2000cited by this paper
• The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.

  1999cited by this paper
• Consensus definitions of subgroups of multiple sclerosis

  1997cited by this paper
• Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques.

  1996cited by this paper
• The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study.

  1993cited by this paper
• The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.

  1989cited by this paper
• Rating neurologic impairment in multiple sclerosis

  1983cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper

• Clinically isolated syndrome: Diagnosis and risk of developing clinically definite multiple sclerosis.

  2023cites this paper
• Ongoing increase in incidence and prevalence of multiple sclerosis in south-eastern Iran: A three decade study.

  2023cites this paper
• Clinically isolated syndrome: diagnosis and risk of developing clinically definite multiple sclerosis.

  2021cites this paper
• Clinical relevance of brain atrophy measures in multiple sclerosis

  2019cites this paper
• The impact of diagnostic criteria and treatments on the 20-year costs for treating relapsing-remitting multiple sclerosis.

  2019cites this paper
• Clinically and Radiological isolated syndrome (MS risk)

  2018cites this paper
• Predicting conversion from clinically isolated syndrome to multiple sclerosis–An imaging-based machine learning approach

  2018influential citation
• Common Clinical and Imaging Conditions Misdiagnosed as Multiple Sclerosis: A Current Approach to the Differential Diagnosis of Multiple Sclerosis.

  2018cites this paper
• How common is truly benign MS in a UK population?

  2018cites this paper
• Use (and misuse) of the McDonald criteria to diagnose multiple sclerosis

  2018cites this paper
• Prognostic value of oligoclonal IgG bands in Japanese clinically isolated syndrome converting to clinically definite multiple sclerosis.

  2017cites this paper
• Diagnosis of multiple sclerosis: progress and challenges.

  2017cites this paper
• Radiologically isolated syndrome and clinically isolated syndrome

  2017cites this paper
• Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.

  2016cites this paper
• Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review

  2015cites this paper
• The role of activated microglia in multiple sclerosis and clinically isolated syndromes : neuroimaging studies

  2015cites this paper
• Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome.

  2015cites this paper
• Clinically isolated syndromes and the relationship to multiple sclerosis.

  2014cites this paper
• The Increasing Prevalence of Multiple Sclerosis in New Zealand

  2014cites this paper
• Noise in multiple sclerosis: unwanted and necessary

  2014cites this paper
• Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis.

  2014cites this paper
• Early prognosis of multiple sclerosis.

  2014cites this paper
• Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria

  2014cites this paper
• Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.

  2014cites this paper
• Revised diagnostic criteria of multiple sclerosis.

  2014cites this paper
• Prédiction d'une atteinte cognitive dans la sclérose en plaques : à qui se fier ?

  2014cites this paper
• Predictors of Conversion toMultiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 RevisedMcDonald Criteria

  2014cites this paper
• Spinal cord lesions in patients with clinically isolated syndrome

  2013cites this paper
• Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study

  2013cites this paper
• Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes

  2013cites this paper
• Cambios e implicaciones en la aplicación de la revisión de criterios de McDonald 2010 en los síndromes clínicamente aislados

  2013cites this paper
• A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden

  2013cites this paper
• 日本人clinically isolated syndrome患者の脳MRI所見

  2012cites this paper
• Clinically isolated syndromes.

  2012cites this paper
• The effect of gender in clinically isolated syndrome (CIS): a meta-analysis

  2012cites this paper
• MS, MRI, and the 2010 McDonald criteria

  2012cites this paper
• [LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants].

  2012cites this paper
• Documento de consenso de LACTRIMS para el tratamiento farmacológico de la esclerosis múltiple y sus variantes clínicas

  2012cites this paper
• Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria

  2012cites this paper
• A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.

  2012cites this paper
• Incidental demyelinating inflammatory lesions in asymptomatic patients: a Brazilian cohort with radiologically isolated syndrome and a critical review of current literature.

  2012cites this paper
• Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study

  2012influential citation
• The Radiologically Isolated Syndrome: Look (Again) Before You Treat

  2011cites this paper
• Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis

  2011influential citation
• Magnetic resonance imaging in multiple sclerosis: the role of conventional imaging.

  2011cites this paper
• Optic neuritis

  2011cites this paper
• A powerful tool in diagnosis and prognosis Spinal cord lesions in patients with clinically isolated syndrome : March 8

  year unknowncites this paper